(Press-News.org) Bacteriophages, viruses that attack and destroy bacteria, are everywhere in the natural world where they play a vital role in regulating microbe populations in ways that are not yet well understood.
New research led by the University of Utah and University College London (UCL) has found that plant bacterial pathogens are able to repurpose elements of their own bacteriophages, or phages, to wipe out competing microbes. These surprise findings suggest such phage-derived elements could someday be harnessed as an alternative to antibiotics, according to Talia Karasov, an assistant professor in the U’s School of Biological Sciences.
This result was hardly what she expected to find when she embarked on this research with an international team of scientists.
Microbial pathogens are all around, but only a fraction of the time do they sicken humans, other animals or plants, according to Karasov, whose primary research interest is in interactions between plants and microbial pathogens. The Karasov lab is seeking to understand the factors that lead to sickness and epidemics versus keeping the pathogens in check.
For its prior research, the lab looked at how a particular bacterial pathogen, Pseudomonas viridiflava, manifests in agricultural and wild settings. On cultivated land, they found, one variant would spread broadly in a crop field and become the dominant microbe present. But that was not the case on uncultivated land, prompting Karasov to find out why.
“We see that no single lineage of bacteria can dominate. We wondered whether the phages, the pathogens of our bacterial pathogens, could prevent single lineages from spreading – maybe phages were killing some strains and not others. That's where our study started, but that's not where it ended up,” Karasov said. “We looked in the genomes of plant bacterial pathogens to see which phages were infecting them. But it wasn't the phage we found that was interesting. The bacteria had taken a phage and repurposed it for warfare with other bacteria, now using it to kill competing bacteria.”
According to her study published this week in Science, the pathogen acquires elements of the phages in the form of non-self-replicating clusters of repurposed phage called tailocins, which penetrate the outer membranes of other pathogens and kill them. After discovering this ongoing warfare in the bacterial pathogen populations, the Karasov lab and lab of Hernán Burbano at UCL mined the genomes of modern and historical pathogens to determine how the bacteria evolve to target one another.
“You can imagine an arms race between the bacteria where they're trying to kill each other and trying to evolve resistance to one another over time,” Burbano said. “The herbarium samples from the past 200 years that we analyzed, provided a window into this arms race, providing insight into how bacteria evade being killed by their competitors.”
Mining herbarium specimens for their microbial DNA
Burbano has pioneered the use of herbarium specimens to explore the evolution of plants and their microbial pathogens. His lab sequences the genomes of both host plants and those of the microbes associated with the plant at the time of collection more than a century ago.
For the phage research, Burbano analyzed historical specimens of Arabidopsis thaliana, a plant from the mustard family commonly called thale cress, collected in southwestern Germany, comparing them and the microbes they harbored to plants growing today in the same part of Germany.
“We discovered that all the historical tailocins were present in our present-day dataset, suggesting that evolution has maintained the diversity of tailocin variants over the century-scale,” he said. “This likely indicates a finite set of possible resistance/sensitivity mechanisms within our studied bacterial population.
Lead author Talia Backman wonders if tailocins could help solve the impending crisis in antibiotic resistance seen in harmful bacteria that infect humans.
“We as a society are in dire need of new antibiotics, and tailocins have potential as new antimicrobial treatments,” said Backman, a graduate student in the Karasov lab. “While tailocins have been found previously in other bacterial genomes, and have been studied in lab settings, their impact and evolution in wild bacterial populations was not known. The fact that we found that these wild plant pathogens all have tailocins and these tailocins are evolving to kill neighboring bacteria shows how significant they may be in nature.”
Like most pesticides, many of our antibiotics were developed decades ago to kill a broad array of harmful organisms, ones that are both harmful and beneficial to human and plant health. Tailocins on the other hand, have greater specificity than most modern antibiotics, killing only a select few strains of bacteria, suggesting they could be deployed without laying waste to entire biological communities.
“This is basic research at this point, not yet ready for application, but I think that there is good potential that this could be adapted for treating infection,” Karasov said. “We as a society have, in how we treat both pests in agriculture and bacterial pathogens in humans, used uniform and broad-spectrum treatments. The specificity of tailocin killing is a way that you could imagine doing more finely tailored treatments.”
Titled “A phage tail–like bacteriocin suppresses competitors in metapopulations of pathogenic bacteria,” the study was published in the June 14 edition of Science. The research was supported by the National Institutes of Health, University of Utah startup funds, the Leverhulme Trust and the Royal Society. Participating in the research with the U School of Biological Sciences were University College London, the Max Planck Institute for Biology, the Complex Carbohydrate Research Center Analytical Services and Training Lab at the University of Georgia, New York University, the U’s Department of Biochemistry and Lawrence Berkeley National Laboratory.
END
The scary, yet promising world of phages, the pathogen's pathogen
2024-06-13
ELSE PRESS RELEASES FROM THIS DATE:
Rising carbon dioxide may be diluting plant nutrients, threatening herbivores
2024-06-13
Smithsonian Conservation Research Brief:
Carbon dioxide-fueled accelerated plant growth dilutes nutrients, impacting herbivore populations.
A new study from researchers at the Smithsonian’s National Zoo and Conservation Biology Institute (NZCBI) warns that as human activities increase carbon dioxide (CO2) levels in the atmosphere, they may decrease the nutrient contents of plants. Declines in nutrient content, known as Nutrient Dilution, may already be harming plant-eating animals and could cause further population declines farther up the ecological chain. The paper, published today in the journal Trends ...
Avi Wigderson to deliver Turing Lecture at ACM Symposium on Theory of Computing
2024-06-13
ACM, the Association for Computing Machinery, is pleased to announce that 2023 ACM A.M. Turing Award recipient Avi Wigderson will give his Turing Lecture at the 2024 ACM Symposium on the Theory of Computing (STOC) on Thursday, June 27 in Vancouver, British Columbia, Canada. Wigderson received the A.M. Turing Award for foundational contributions to the theory of computation, including reshaping our understanding of the role of randomness in computation, and for his decades of intellectual leadership in theoretical computer science.
In "Alan Turing: A TCS Role Model," Wigderson ...
Researchers to develop predictive model for opioid addiction in high-risk patients
2024-06-13
Opioids are a broad group of effective pain-relieving medicines that can become highly addictive in some individuals. According to government sources, nearly 40 million people are addicted to illicit drugs worldwide. In 2017, the U.S. Department of Health and Human Services declared the opioid crisis a national public health emergency. To combat the opioid epidemic, researchers at University of California San Diego School of Medicine will develop an AI model that will more accurately predict opioid addiction in high-risk patients.
The project is funded through a three-year contract with Wellcome Leap as part of a $50 million groundbreaking initiative, called ...
ADHD meds may help pregnant patients control opioid use disorder
2024-06-13
Opioid overdoses for pregnant patients are at an all-time high in the United States, even as overall numbers are improving. Attention deficit hyperactivity disorder (ADHD) is highly correlated with substance use disorders, yet treatment protocols to help expecting parents manage opioid use disorders and ADHD together are essentially nonexistent.
New research from Washington University School of Medicine in St. Louis may help change that. A study published in Nature Mental Health indicates that patients with opioid use disorders and ADHD who remain on their ADHD medications during their pregnancies are far more likely to adhere to treatment for opioid use, and far less likely to ...
Watery planets orbiting dead stars may be good candidates for studying life — if they can survive long enough
2024-06-13
The small footprint and dim light of white dwarfs, remnants of stars that have burned through their fuel, may make excellent backdrops for studying planets with enough water to harbor life.
The trick is spotting the shadow of a planet against a former star that has withered to a fraction of its size and finding that it’s a planet that has kept its water oceans for billions of years even after riding out the star’s explosive and violent final throes. A new study of the dynamics of white dwarf systems suggests that, in theory, some watery planets may indeed thread the celestial needles necessary to await ...
Reinvigorating exhausted immune cells reveals potential therapy target for cancer
2024-06-13
The ecosystem that surrounds a tumor, also known as the tumor microenvironment, includes immune cells, tissues, blood vessels and other cells that interact with each other and with the tumor. Over time, the tumor shapes this ecosystem to its own benefit, monopolizing all of the nutrients and shielding it from immune attack. In working to understand the ecosystem’s role in cancer risk, development and treatment, researchers at The Jackson Laboratory have not only identified how two immune cells work together to fight cancer but also revealed the cascade of molecules that help coordinate this attack.
The work, ...
After major traumatic brain injury, more blood transfusions could mean better outcomes
2024-06-13
Québec City, June 13, 2024–Increased use of blood transfusions after major traumatic brain injury could help people hospitalized in intensive care units regain greater functional independence and a better quality of life.
Six months after a major traumatic brain injury (TBI), patients who benefited from this approach regained more functional independence and had a better quality of life than those subjected to a more restrictive approach, even though the combined incidence of death and major ...
Low-dose glucocorticoids in SLE
2024-06-13
In a session on diagnosing and managing complex diseases at the 2024 EULAR congress in Vienna, two abstracts tackled this issue.
First, Filippo Vesentini presented on the risk of flare with glucocorticoid compared to low-dose maintenance – based on a retrospective analysis of prospectively collected data from people with SLE. Flare-free remission and predictors of such were evaluated respectively in remitted patients on and off glucocorticoids.
During follow-up, 484 patients achieved remission at least once during ...
Implementing physical activity recommendations
2024-06-13
An HPR abstract sessions at the 2024 EULAR congress looked specifically at harnessing the benefits of exercise in rheumatic and musculoskeletal diseases (RMD) – and the challenges to their practical implementation.
Mohamed Saadi presented a systematic review examining barriers and facilitators affecting adherence to EULAR’s physical activity recommendations. Across 68 selected articles, 29 different themes were identified – 9 of which were social, 16 environmental, and 4 systemic. The five most frequently found themes were having supportive family and friends, a supportive health professional, followed by costs, and access or proximity to adapted and ...
Achieving drug-free remission in AXSPA
2024-06-13
Even though early therapeutic interventions have proven successful in inducing drug-free remission in other inflammatory rheumatic diseases, such studies remain difficult to conduct in axial spondyloarthritis (axSpA), which manifests itself by insidious onset inflammatory back pain. As a result it is often diagnosed late,5 and a consensus definition of early disease was only recently published.6
At the 2024 EULAR congress, Łukasik and colleagues shared data from their prospective study evaluating the efficacy of a ...